Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghainyou Medical CoSHSE:688085 +0.22%79 Cyclically Adjusted PS Ratio is 10.53 as of Aug. 13, 2026, which is 27% below its 10-year median of 14.37. GuruFocus rates SHSE:688085 with a GF Score™ of 79/100 and a GF Value™ of ¥15.94 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 525 Medical Devices & Instruments companies, Shanghainyou Medical Co ranks worse than 88% on this metric.
The historical rank and industry rank for Shanghainyou Medical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:
SHSE:688085'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 10.5 Med: 14.37 Max: 16.98
Current: 10.5
During the past 10 years, Shanghainyou Medical Co's highest Cyclically Adjusted PS Ratio was 16.98. The lowest was 10.50. And the median was 14.37.
SHSE:688085's Cyclically Adjusted PS Ratio is ranked worse than 88% of 525
companies
in the Medical Devices & Instruments industry
Industry Median: 2.3
vs SHSE:688085: 10.50
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Shanghainyou Medical Co's adjusted revenue per share data of for the fiscal year that ended in Dec25 was ¥1.486. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.31 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Shanghainyou Medical Co (SHSE:688085) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Shanghainyou Medical Co Cyclically Adjusted PS Ratio Related Terms
Shanghainyou Medical Co Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Shanghainyou Medical Co's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghainyou Medical Co Cyclically Adjusted PS Ratio Chart
SHSE:688085 vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison
For the Medical Devices subindustry, Shanghainyou Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghainyou Medical Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghainyou Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Shanghainyou Medical Co's Cyclically Adjusted PS Ratio falls into.
Shanghainyou Medical Co Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 10.53 mean?
Shanghainyou Medical Co (SHSE:688085) has a Cyclically Adjusted PS Ratio of 10.53 as of Aug. 13, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghainyou Medical Co and its competitors. This is 27% below median its historical median of 14.37. Over the past decade, Shanghainyou Medical Co's Cyclically Adjusted PS Ratio has ranged from 10.50 to 16.98. According to the industry distribution chart, Shanghainyou Medical Co ranks #462 out of 525 companies in the Medical Devices & Instruments industry, placing it in the top 88%.
Is Shanghainyou Medical Co's Cyclically Adjusted PS Ratio too high?
Shanghainyou Medical Co's current Cyclically Adjusted PS Ratio of 10.53 is 27% below median its 10-year median of 14.37. Over the past 10 years, this metric has ranged from a low of 10.50 to a high of 16.98. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.30. Shanghainyou Medical Co's value of 10.53 is 357.8% above this industry median. Based on the distribution chart, Shanghainyou Medical Co ranks #462 out of 525 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghainyou Medical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghainyou Medical Co's Cyclically Adjusted PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghainyou Medical Co ranks #462 out of 525 companies for Cyclically Adjusted PS Ratio. This places Shanghainyou Medical Co in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 2.30. Shanghainyou Medical Co's value of 10.53 is 357.8% above this benchmark. Historically, Shanghainyou Medical Co's own Cyclically Adjusted PS Ratio has ranged from 10.50 to 16.98 over the past decade. While the company's 10-year median is 14.37 vs. the industry median of 2.30, Shanghainyou Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.30, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghainyou Medical Co's current Cyclically Adjusted PS Ratio of 10.53 is 357.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghainyou Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghainyou Medical Co's current Cyclically Adjusted PS Ratio is 10.53, which is 27% below median its own 10-year median of 14.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghainyou Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghainyou Medical Co (SHSE:688085) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.94, compared to a current price of ¥13.80 — trading 13.4% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 10.53, which is 27% below median its 10-year median of 14.37 and 357.8% above the Medical Devices & Instruments industry median of 2.30. Shanghainyou Medical Co's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Shanghainyou Medical Co (SHSE:688085), the current Cyclically Adjusted PS Ratio is 10.53 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghainyou Medical Co (SHSE:688085) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghainyou Medical Co stock appears to be undervalued.
The current stock price of ¥13.80 is trading 13.4% below its estimated GF Value™ of ¥15.94.
GuruFocus considers Shanghainyou Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688085:
Cyclically Adjusted PS Ratio: 10.53 (27% below median its 10-year median of 14.37)
GF Value™: ¥15.94 vs. price of ¥13.80 (13.4% below fair value)
Industry Position: 357.8% above the Medical Devices & Instruments median (#462 of 525)
No single metric tells the full story. See the SHSE:688085 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Sanyou Medical Co Ltd is engaged in manufacturing and sales of independently orthopedics implant. The company manufactures medical devices such as type III implantation equipment (orthopedics), type III intracranial hematoma puncture removal equipment, type II dressing, nursing materials, type II surgical instruments and I surgical instruments.
79GF Score
Get the complete analysis for SHSE:688085
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688085 has been successfully added to your 
